Impact of Cytomegalovirus infection on immune signatures in cancer patients.
作者信息
Derhovanessian Evelyna
出版信息
Cancer Immunol Immunother. 2010 Feb;59(2):335-6; author reply 337. doi: 10.1007/s00262-009-0767-7. Epub 2009 Sep 17.
Abstract
摘要
相似文献
1
Impact of Cytomegalovirus infection on immune signatures in cancer patients.
Cancer Immunol Immunother. 2010 Feb;59(2):335-6; author reply 337. doi: 10.1007/s00262-009-0767-7. Epub 2009 Sep 17.
2
Is immunosenescence infectious?
Trends Immunol. 2004 Aug;25(8):406-10. doi: 10.1016/j.it.2004.05.006.
3
Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection.
Cancer Immunol Immunother. 2010 Feb;59(2):323-34. doi: 10.1007/s00262-009-0753-0.
4
Dynamics of T cell memory in human cytomegalovirus infection.
Med Microbiol Immunol. 2008 Jun;197(2):83-96. doi: 10.1007/s00430-008-0082-5. Epub 2008 Feb 27.
5
Cytomegalovirus infection and progressive differentiation of effector-memory T cells.
F1000Res. 2018 Sep 26;7. doi: 10.12688/f1000research.15753.1. eCollection 2018.
6
T cell responses to cytomegalovirus.
Nat Rev Immunol. 2016 Jun;16(6):367-77. doi: 10.1038/nri.2016.38. Epub 2016 Apr 25.
7
8
No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study.
J Infect Dis. 2017 Mar 15;215(6):883-888. doi: 10.1093/infdis/jix064.
9
Memory T cell inflation: understanding cause and effect.
Trends Immunol. 2012 Feb;33(2):84-90. doi: 10.1016/j.it.2011.11.005. Epub 2012 Jan 3.
10
The avid competitors of memory inflation.
Curr Opin Virol. 2020 Oct;44:162-168. doi: 10.1016/j.coviro.2020.08.007. Epub 2020 Oct 8.
引用本文的文献
1
Vaccination in the elderly.
Microb Biotechnol. 2012 Mar;5(2):226-32. doi: 10.1111/j.1751-7915.2011.00283.x. Epub 2011 Aug 31.
本文引用的文献
1
Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection.
Cancer Immunol Immunother. 2010 Feb;59(2):323-34. doi: 10.1007/s00262-009-0753-0.
2
Immunosenescence and vaccine failure in the elderly.
Aging Clin Exp Res. 2009 Jun;21(3):201-9. doi: 10.1007/BF03324904.
3
Biomarkers of human immunosenescence: impact of Cytomegalovirus infection.
Curr Opin Immunol. 2009 Aug;21(4):440-5. doi: 10.1016/j.coi.2009.05.012. Epub 2009 Jun 15.
4
Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.
Clin Exp Immunol. 2009 Mar;155(3):423-32. doi: 10.1111/j.1365-2249.2008.03785.x.
5
Cytomegalovirus and human immunosenescence.
Rev Med Virol. 2009 Jan;19(1):47-56. doi: 10.1002/rmv.598.
6
Dynamics of T cell memory in human cytomegalovirus infection.
Med Microbiol Immunol. 2008 Jun;197(2):83-96. doi: 10.1007/s00430-008-0082-5. Epub 2008 Feb 27.
7
Challenges for vaccination in the elderly.
Immun Ageing. 2007 Dec 11;4:9. doi: 10.1186/1742-4933-4-9.
8
Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.
Clin Microbiol Infect. 2008 Mar;14(3):221-7. doi: 10.1111/j.1469-0691.2007.01895.x. Epub 2007 Dec 5.
9
A fingerprint left by cytomegalovirus infection in the human T cell compartment.
J Clin Virol. 2008 Mar;41(3):213-7. doi: 10.1016/j.jcv.2007.10.016. Epub 2007 Dec 3.
10
T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.
J Immunol. 2007 Apr 1;178(7):4455-65. doi: 10.4049/jimmunol.178.7.4455.
Zotero 插件